scispace - formally typeset
S

Si-Xue Cheng

Researcher at Wuhan University

Publications -  238
Citations -  12634

Si-Xue Cheng is an academic researcher from Wuhan University. The author has contributed to research in topics: Drug carrier & Micelle. The author has an hindex of 54, co-authored 236 publications receiving 10754 citations. Previous affiliations of Si-Xue Cheng include Sichuan University & University of South China.

Papers
More filters
Journal ArticleDOI

Study on the drug release property of cholesteryl end‐functionalized poly(ε‐caprolactone) microspheres

TL;DR: End-functionalized poly/oligo(epsilon-caprolactone)s were synthesized through the ring-opening polymerization of epsilon-caproactone initiated by cholesterol with a hydroxyl group using a convenient melting-emulsion method.
Journal ArticleDOI

Degradation and drug release property of star poly(epsilon-caprolactone)s with dendritic cores.

TL;DR: The results show the hydrolytic degradation rate increases with increasing content of hydrophilic PAMAM-OH core, and the catalytic effect of Pseudomonas cepacia lipase on the degradation of PCL branches and the hydrophilicity that depends on the polymer composition.
Journal ArticleDOI

Co-delivery of multiple drug resistance inhibitors by polymer/inorganic hybrid nanoparticles to effectively reverse cancer drug resistance.

TL;DR: The study on immunostimulatory effects of different treatments showed that BSO/CXB@BNP treatment resulted in the lowest concentration of interleukin 10, a cytokine related to tumor development, suggesting the nanoparticulate drug delivery platform developed in this study has promising applications in multiple drug delivery to overcome drug resistance in tumor treatments.
Journal ArticleDOI

Universal Porphyrinic Metal–Organic Framework Coating to Various Nanostructures for Functional Integration

TL;DR: It was demonstrated that this modification strategy can realize controlled growth of porphyrin MOF on a series of organic and inorganic nanostructures, such as polydopamine (PDA) nanoparticles, PDA@Pt nanoparticles), graphene oxide sheets, and Au nanorods.
Journal ArticleDOI

Biotinylated carboxymethyl chitosan/CaCO3 hybrid nanoparticles for targeted drug delivery to overcome tumor drug resistance

TL;DR: In vitro study showed that BCMC/CaCO3/DOX/TQR nanoparticles exhibited obviously enhanced cell uptake and nuclear localization as compared with the free DOX and the single-drug loaded nanoparticles because of the efficient inhibition of P-glycop protein mediated efflux.